A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
Christopher A. Barker,Sandra P. D’Angelo,Gloria Wasilewski,Alexa Steckler,Ming Lian,Zhigang Zhang,Paul B. Chapman,Alexander N. Shoushtari,Charlotte E. Ariyan